ASCO GU recap: Vignesh Packiam, MD, on key bladder cancer highlights

Recent data presented at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco, California, highlighted several developments in bladder cancer management, including efforts to address treatment shortages, refine bladder-preservation strategies, and expand the role of circulating biomarkers, according to Vignesh T. Packiam, MD, associate professor of urology at the Rutgers Cancer Institute of New Jersey. In the following video, Packiam reviews several studies presented at the meeting that he described as clinically meaningful for practicing urologists, particularly as the field continues to navigate limitations in standard therapies and explore new multimodal treatment strategies.